New developments in the management of major depressive disorder and generalized anxiety disorder: role of quetiapine

References

• AlexiadisMWhitehornDWoodleyH2002Prolactin elevation with quetiapineAm J Psychiatry1591608912202292
   PubMed Web of Science ®Google Scholar
• AnanthJ1998Treatment-resistant depressionPsychother Psychosom6761709556196
   PubMed Web of Science ®Google Scholar
• ArangoCBernardoM2005The effect of quetiapine on aggression and hostility in patients with schizophreniaHum Psychopharmacol202374115830402
   PubMed Web of Science ®Google Scholar
• AtmacaMKulogluMTezcanE2002Quetiapine is not associated with increase in prolactin secretion in contrast to haloperidolArch Med Res33562512505103
   PubMed Web of Science ®Google Scholar
• BarnesTR1989A rating scale for drug-induced akathisiaBr J Psychiatry15467262574607
   PubMed Web of Science ®Google Scholar
• BauneBTCaliskanSTodderD2007Effects of adjunctive antidepressant therapy with quetiapine on clinical outcome, quality of sleep and daytime motor activity in patients with treatment-resistant depressionHum Psychopharmacol221917191266
   PubMed Web of Science ®Google Scholar
• BerkMDoddS2005Efficacy of atypical antipsychotics in bipolar disorderDrugs652576915631544
   PubMed Web of Science ®Google Scholar
• CalabreseJRKeckPEJrMacfaddenW2005A randomized, double-blind, placebo-controlled trial of quetiapine in the treatment of bipolar I or II depressionAm J Psychiatry16213516015994719
   PubMed Web of Science ®Google Scholar
• ChouinardGAhokasABandelowB2008Once-daily extended release quetiapine fumarate (quetiapine XR) monotherapy in generalized anxiety disorder (GAD): a placebo-controlled study with active-comparator paroxetineAnxiety Disorders Association of America CongressSavannah, Georgia, USA
   Google Scholar
• CohrsSRodenbeckAGuanZ2004Sleep-promoting properties of quetiapine in healthy subjectsPsychopharmacology (Berl)174421915029469
   PubMed Web of Science ®Google Scholar
• CroissantBKleinOGehrleinL2006Quetiapine in relapse prevention in alcoholics suffering from craving and affective symptoms: a case seriesEur Psychiatry21570317161284
   PubMed Web of Science ®Google Scholar
• DandoTMKeatingGM2005Quetiapine: a review of its use in acute mania and depression associated with bipolar disorderDrugs6525335116296876
   PubMed Web of Science ®Google Scholar
• DannlowskiUBauneBTBockermannIin pressAdjunctive antidepressant treatment with quetiapine in agitated depression: positive effects on symptom reduction, psychopathology and remission ratesHum Psychopharmacol
   Web of Science ®Google Scholar
• DattoCLamRLepolaU2008Double-blind study of extended release quetiapine fumarate (quetiapine XR) monotherapy for maintenance treatment of major depressive disorder (MDD)161st Annual Meeting of the American Psychiatric AssociationWashington DC, USA
   Google Scholar
• DeVaneCLNemeroffCB2001Clinical pharmacokinetics of quetiapine: an atypical antipsychoticClin Pharmacokinet405092211510628
   PubMed Web of Science ®Google Scholar
• DiazENeuseESullivanMCPearsallHRWoodsSW2004Adherence to conventional and atypical antipsychotics after hospital dischargeJ Clin Psychiatry653546015096075
   PubMed Web of Science ®Google Scholar
• DoreeJPDes RosiersJLewV2007Quetiapine augmentation of treatment-resistant depression: a comparison with lithiumCurr Med Res Opin233334117288688
   PubMed Web of Science ®Google Scholar
• El-KhaliliNBanovMBortnickB2008aEfficacy and tolerability of extended release quetiapine fumarate (quetiapine XR) monotherapy in major depressive disorder (MDD): a randomized, placebo-controlled clinical trial (Study 003)63rd Annual Society of Biological PsychiatryWashington DC, USA
   Google Scholar
• El-KhaliliNJoyceMAtkinsonS2008bAdjunctive extended-release quetiapine fumarate (quetiapine XR) in patients with major depressive disorder and inadequate antidepressant response161st Annual Meeting of the American Psychiatric AssociationWashington DC, USA
   Google Scholar
• FavaMDavidsonKG1996Definition and epidemiology of treatment-resistant depressionPsychiatr Clin North Am191792008827185
   PubMed Web of Science ®Google Scholar
• FerrierIN1999Treatment of major depression: is improvement enough?J Clin Psychiatry60Suppl 610410235119
   PubMed Web of Science ®Google Scholar
• GaoKMuzinaDGajwaniP2006Efficacy of typical and atypical antipsychotics for primary and comorbid anxiety symptoms or disorders: a reviewJ Clin Psychiatry6713274017017818
   PubMed Web of Science ®Google Scholar
• GefvertOBergstromMLangstromB1998Time course of central nervous dopamine-D2 and 5-HT2 receptor blockade and plasma drug concentrations after discontinuation of quetiapine (Seroquel) in patients with schizophreniaPsychopharmacology (Berl)135119269497016
   PubMed Web of Science ®Google Scholar
• GhaemiSNKatzowJJ1999The use of quetiapine for treatment-resistant bipolar disorder: a case seriesAnn Clin Psychiatry111374010482123
   PubMedGoogle Scholar
• HanleyMJKennaGA2008Quetiapine: treatment for substance abuse and drug of abuseAm J Health Syst Pharm65611818359967
   PubMed Web of Science ®Google Scholar
• HirschfeldRMWeislerRHRainesSR2006Quetiapine in the treatment of anxiety in patients with bipolar I or II depression: a secondary analysis from a randomized, double-blind, placebo-controlled studyJ Clin Psychiatry673556216649820
   PubMed Web of Science ®Google Scholar
• IskedjianMEinarsonTRMackeiganLD2002Relationship between daily dose frequency and adherence to antihypertensive pharmaco-therapy: evidence from a meta-analysisClin Ther243021611911560
   PubMed Web of Science ®Google Scholar
• JensenNHRodriguizRMCaronMG2008N-desalkylquetiapine, a potent norepinephrine reuptake inhibitor and partial 5-HT1A agonist, as a putative mediator of quetiapine’s antidepressant activityNeuropsychopharmacology3323031218059438
   PubMed Web of Science ®Google Scholar
• KahnRSSchulzSCPalazovVD2007Efficacy and tolerability of once-daily extended release quetiapine fumarate in acute schizophrenia: a randomized, double-blind, placebo-controlled studyJ Clin Psychiatry688324217592906
   PubMed Web of Science ®Google Scholar
• KapurSZipurskyRJonesC2000A positron emission tomography study of quetiapine in schizophrenia: a preliminary finding of an antipsychotic effect with only transiently high dopamine D2 receptor occupancyArch Gen Psychiatry57553910839333
   PubMed Web of Science ®Google Scholar
• KatzmanMAVermaniMJacobsLin pressQuetiapine as an adjunctive pharmacotherapy for the treatment of non-remitting generalized anxiety disorder: A flexible-dose, open-label pilot trialJ Anxiety Disord
   Web of Science ®Google Scholar
• KatzmanMBrawman-MintzerOReyesE2008Extended release quetiapine fumarate (quetiapine XR) monotherapy in maintenance treatment of generalized anxiety disorder (GAD): efficacy and tolerability results from a randomized, placebo-controlled trial63rd Annual Society of Biological PsychiatryWashington, DC, USA
   Google Scholar
• KeatingGMRobinsonDM2007Quetiapine: a review of its use in the treatment of bipolar depressionDrugs6710779517488148
   PubMed Web of Science ®Google Scholar
• KennedySHLamRW2003Enhancing outcomes in the management of treatment resistant depression: a focus on atypical antipsychoticsBipolar Disord5Suppl 2364714700011
   PubMed Web of Science ®Google Scholar
• KhanAJoyceMEggensI2008Extended release quetiapine fumarate (quetiapine XR) monotherapy in the treatment of patients with generalized anxiety disorder (GAD)Anxiety Disorders Association of America CongressSavannah, Georgia, USA
   Google Scholar
• KhazaalYTapparelSChattonA2007Quetiapine dosage in bipolar disorder episodes and mixed statesProg Neuropsychopharmacol Biol Psychiatry317273017291654
   PubMed Web of Science ®Google Scholar
• MollerHJJohnsonSMatevaT2008Evaluation of the feasibility of switching from immediate release quetiapine to extended release quetiapine fumarate in stable outpatients with schizophreniaInt Clin Psychopharmacol239510518301124
   PubMed Web of Science ®Google Scholar
• MontgomerySCutlerALazarusA2008Extended release quetiapine fumarate (quetiapine XR) monotherapy in the treatment of patients with major depressive disorder (MDD)16th European Congress of PsychiatryNice, France
   Google Scholar
• NakoneznyPAByerlyMJRushAJ2007The relationship between serum prolactin level and sexual functioning among male outpatients with schizophrenia or schizoaffective disorder: a randomized double-blind trial of risperidone vs quetiapineJ Sex Marital Ther332031617454518
   PubMed Web of Science ®Google Scholar
• NemeroffCB2005Use of atypical antipsychotics in refractory depression and anxietyJ Clin Psychiatry66Suppl 8132116336032
   PubMed Web of Science ®Google Scholar
• NierenbergAAWrightEC1999Evolution of remission as the new standard in the treatment of depressionJ Clin Psychiatry60Suppl 2271110634349
   PubMed Web of Science ®Google Scholar
• PhilipNSCarpenterLLTyrkaAR2008Augmentation of antidepressants with atypical antipsychotics: a review of the current literatureJ Psychiatr Pract14344418212601
   PubMed Web of Science ®Google Scholar
• RichelsonESouderT2000Binding of antipsychotic drugs to human brain receptors focus on newer generation compoundsLife Sci68293911132243
   PubMed Web of Science ®Google Scholar
• RushATrivediMT1995Treating depression to remissionPsychiatr Ann97045
   Web of Science ®Google Scholar
• SagudMMihaljevic-PelesAMuck-SelerD2006Quetiapine augmentation in treatment-resistant depression: a naturalistic studyPsychopharmacology (Berl)187511416802162
   PubMed Web of Science ®Google Scholar
• SallerCFSalamaAI1993Seroquel: biochemical profile of a potential atypical antipsychoticPsychopharmacology (Berl)112285927871032
   PubMed Web of Science ®Google Scholar
• SattarSPBhatiaSCPettyF2004Potential benefits of quetiapine in the treatment of substance dependence disordersJ Psychiatry Neurosci29452715644986
   PubMed Web of Science ®Google Scholar
• SavaskanESchnitzlerCSchroderC2006Treatment of behavioural, cognitive and circadian rest-activity cycle disturbances in Alzheimer’s disease: haloperidol vs. quetiapineInt J Neuropsychopharmacol95071616316485
   PubMed Web of Science ®Google Scholar
• SheltonRCPapakostasGI2008Augmentation of antidepressants with atypical antipsychotics for treatment-resistant major depressive disorderActa Psychiatr Scand117253918190674
   PubMed Web of Science ®Google Scholar
• SimpsonGMAngusJW1970A rating scale for extrapyramidal side effectsActa Psychiatr Scand Suppl2121194917967
   PubMedGoogle Scholar
• SokolskiKNDensonTF2003Adjunctive quetiapine in bipolar patients partially responsive to lithium or valproateProg Neuropsychopharmacol Biol Psychiatry27863612921920
   PubMed Web of Science ®Google Scholar
• SrisurapanontMManeetonBManeetonN2004Quetiapine for schizophreniaCochrane Database Syst RevCD00096715106155
   PubMedGoogle Scholar
• Tauscher-WisniewskiSKapurSTauscherJ2002Quetiapine: an effective antipsychotic in first-episode schizophrenia despite only transiently high dopamine-2 receptor blockadeJ Clin Psychiatry63992712444812
   PubMed Web of Science ®Google Scholar
• ThaseMEMacfaddenWWeislerRH2006Efficacy of quetiapine monotherapy in bipolar I and II depression: a double-blind, placebo-controlled study (the BOLDER II study)J Clin Psychopharmacol26600917110817
   PubMed Web of Science ®Google Scholar
• TodderDCaliskanSBauneBT2006Night locomotor activity and quality of sleep in quetiapine-treated patients with depressionJ Clin Psychopharmacol266384217110822
   PubMed Web of Science ®Google Scholar
• VietaE2005Mood stabilization in the treatment of bipolar disorder: focus on quetiapineHum Psychopharmachol3 [Epub ahead of print]
   Google Scholar
• WeislerRHCalabreseJRThaseME2008bEfficacy of quetiapine monotherapy for the treatment of depressive episodes in bipolar I disorder: a post hoc analysis of combined results from 2 double-blind, randomized, placebo-controlled studiesJ Clin Psychiatry697698218452345
   PubMed Web of Science ®Google Scholar
• WeislerRJoyceMMcGillL2008aExtended release quetiapine fumarate (quetiapine XR) monotherapy for major depressive disorder (MDD): a double-blind, placebo-controlled studyAmerican Psychiatric AssociationWashington, DC, USA
   Google Scholar